Background <p>Endoscopic radial artery harvesting (ERAH) is a minimally invasive alternative to open radial artery harvesting (ORAH) for coronary artery bypass grafting (CABG), though concerns persist regarding graft patency and neurological outcomes.</p> Methods <p>PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched through February 21, 2026. Randomized controlled trials and propensity-matched observational studies were included. Risk of bias was assessed using ROB 2 and the Newcastle-Ottawa Scale; certainty of evidence was evaluated using GRADE. Pooled risk ratios and mean differences with 95% confidence intervals were calculated using a random-effects model.</p> Results <p>ERAH significantly reduced wound complications (RR = 0.61, 95% CI: 0.39–0.96) and wound infections (RR = 0.57, 95% CI: 0.35–0.93), though this benefit did not persist in RCT-only analysis. Neurological complications were reduced after sensitivity analysis (RR = 0.44, 95% CI: 0.34–0.57). Graft patency was comparable (RR = 1.01, 95% CI: 0.90–1.14), with no significant differences in mortality, MACCE, or myocardial infarction. Observational data showed modest reductions in cardiopulmonary bypass time and hospital stay.</p> Conclusions <p>ERAH demonstrates comparable graft patency and major clinical outcomes to ORAH. Donor-site benefits suggested by observational studies are not consistently supported by randomized evidence. Large trials with standardized outcomes and long-term follow-up are needed.</p> Trial registration <p>PROSPERO, CRD420261334767.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Endoscopic versus open radial artery harvesting for coronary artery bypass grafting: an updated systematic review, meta-analysis, and GRADE assessment

  • Tayyaba Ikram Qazi,
  • Aleena Amir Malik,
  • Mariya Khan,
  • Muhammad Yahya,
  • Yashfa Asad,
  • Sarah Idrees,
  • Muhammad Uzair Gull,
  • Abbas Khan,
  • Faiza Munir,
  • Abdul Saboor Khan,
  • Atiqullah Sadaqat,
  • Muhammad Maaz Amjad,
  • Pari Kotak,
  • Muhammad Ahmad Akif Rauf,
  • Sajid Rehman,
  • Muhammad Yasir,
  • Muhammad Huzaifa Khattak,
  • Hamza Wazir Khan,
  • Asia Batool,
  • Haris Wazir Khan,
  • Bilal Wazir Khan

摘要

Background

Endoscopic radial artery harvesting (ERAH) is a minimally invasive alternative to open radial artery harvesting (ORAH) for coronary artery bypass grafting (CABG), though concerns persist regarding graft patency and neurological outcomes.

Methods

PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched through February 21, 2026. Randomized controlled trials and propensity-matched observational studies were included. Risk of bias was assessed using ROB 2 and the Newcastle-Ottawa Scale; certainty of evidence was evaluated using GRADE. Pooled risk ratios and mean differences with 95% confidence intervals were calculated using a random-effects model.

Results

ERAH significantly reduced wound complications (RR = 0.61, 95% CI: 0.39–0.96) and wound infections (RR = 0.57, 95% CI: 0.35–0.93), though this benefit did not persist in RCT-only analysis. Neurological complications were reduced after sensitivity analysis (RR = 0.44, 95% CI: 0.34–0.57). Graft patency was comparable (RR = 1.01, 95% CI: 0.90–1.14), with no significant differences in mortality, MACCE, or myocardial infarction. Observational data showed modest reductions in cardiopulmonary bypass time and hospital stay.

Conclusions

ERAH demonstrates comparable graft patency and major clinical outcomes to ORAH. Donor-site benefits suggested by observational studies are not consistently supported by randomized evidence. Large trials with standardized outcomes and long-term follow-up are needed.

Trial registration

PROSPERO, CRD420261334767.